What Are Treatments for Recurrent Respiratory Papillomatosis?
Discussion
Human papilloma virus (HPV) is a member of the Papillomaviridae virus family with over a 150 different subtypes. HPV can cause cervical, genital and respiratory tract papillomas. HPV is often benign but can cause anogenital, cervical and head and neck cancers.
Recurrent respiratory papillomatosis (RRP) is uncommon but can cause significant morbidity while awaiting the body’s immune system to respond. There is a juvenile and adult form, and the incidence varies between 2-4/100,000 in the pediatric population. The juvenile form frequently occurs between 3.6-6 years of age and in general the younger the patie...
Source: PediatricEducation.org - July 31, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Four 'main' symptoms of head and neck cancer - surgeon's advice
More than 12,000 people in the UK are diagnosed with this disease every year. (Source: Daily Express - Health)
Source: Daily Express - Health - July 27, 2023 Category: Consumer Health News Source Type: news
Radiation Approach Improves Swallowing in Head, Neck Cancer Radiation Approach Improves Swallowing in Head, Neck Cancer
A new strategy that limits radiation to the muscles responsible for swallowing can significantly reduce the incidence of dysphagia among patients with head and neck cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Novel Turmeric Derivative Drug Shows Promise in Head and Neck Cancer
(MedPage Today) -- MONTREAL – An investigational drug derived from turmeric (Curcuma longa) appeared to have activity in patients being evaluated for head and neck cancer therapy, at least in an early phase trial.
All nine oropharyngeal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 11, 2023 Category: Hematology Source Type: news
IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer
(MedPage Today) -- In patients with head and neck cancer, a strategy to reduce the radiation dose to dysphagia-and aspiration-related structures improved swallowing and other functional outcomes compared with standard intensity-modulated radiotherapy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 8, 2023 Category: Hematology Source Type: news
Overweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
FRIDAY, June 30, 2023 -- Overweight body mass index (BMI) is associated with favorable outcomes in patients with nonmetastatic head and neck cancer undergoing chemoradiotherapy, according to a study published online June 27 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2023 Category: Pharmaceuticals Source Type: news
Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
THURSDAY, June 29, 2023 -- The burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with head and neck squamous cell carcinoma (HNSCC), according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2023 Category: Pharmaceuticals Source Type: news
Patients With High BMI Fare Better in Head and Neck Cancer Patients With High BMI Fare Better in Head and Neck Cancer
Patients with head and neck cancer and obesity saw better treatment response and survival after chemoradiation, compared with patients with the same type of cancer but a normal weight.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 29, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
How the Shortage of a $15 Cancer Drug Is Upending Treatment
Older generic chemotherapy drugs remain scarce, forcing doctors to put a priority on the patients who have the best chance of survival. (Source: NYT Health)
Source: NYT Health - June 26, 2023 Category: Consumer Health News Authors: Christina Jewett Tags: Shortages Drugs (Pharmaceuticals) Cancer Chemotherapy Deaths (Fatalities) Doctors Head and Neck Cancer Supply Chain Breast Cancer Rationing and Allocation of Resources Accord Healthcare American Cancer Society Food and Drug Adminis Source Type: news
PET predicts 'dry mouth' side effect in radiotherapy patients
PET/CT scans taken midway through radiotherapy in head and neck cancer patient...Read more on AuntMinnie.comRelated Reading:
Second-look PET/CT catches cancer spread
PET/CT shows promise predicting outcomes in head, neck cancer
Can 3D-printed shields protect patients during radiation therapy?
PSMA-PET reveals new salivary glands
PET/MRI boosts cancer detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 23, 2023 Category: Radiology Source Type: news
Metronomic Therapy Effective in Head and Neck Cancer Metronomic Therapy Effective in Head and Neck Cancer
In the second-line setting of head and neck cancer, metronomic triple therapy outperformed clinician choice chemotherapy in both progression-free survival and overall survival.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer
(MedPage Today) -- Use of weekly adaptive radiotherapy (RT) failed to decrease xerostomia (dry mouth) in oropharyngeal cancer patients when compared with standard intensity-modulated RT (IMRT), the phase III ARTIX trial found.
Of the 131 patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 1, 2023 Category: Hematology Source Type: news
Lupin Partners Enzene to roll out biosimilar Cetuximab here
In July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic colorectal cancer and head and neck cancer. Head and neck cancer presents a significant public health challenge in India, with a staggering annual incidence of over 100,000 new cases. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 30, 2023 Category: Pharmaceuticals Source Type: news
Lupin launches biosimilar cetuximab in pact with Enzene
Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer (Source: The Economic Times)
Source: The Economic Times - May 30, 2023 Category: Consumer Health News Source Type: news
Six neck cancer warning signs revealed after death of paedophile TV presenter Rolf Harris
Around 12,400 new cases of head and neck cancers are diagnosed in the UK each year, with roughly 66,000 in the US. But symptoms can be hard to spot, according to the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2023 Category: Consumer Health News Source Type: news
